Related Experiment Videos
Work in progress. Gastrointestinal ulcerations: detection using a technetium-99m-labeled ulcer-avid agent.
Radiology
|July 1, 1983
Summary
Technetium-99m-labeled sucralfate shows promise for visualizing gastrointestinal ulcers. This ulcer-avid agent is stable in vivo and demonstrated good sensitivity in preliminary human and animal studies.
Area of Science:
- Nuclear medicine
- Gastroenterology
- Radiopharmaceutical development
Background:
- Sucralfate is an ulcer-adherent medication.
- Technetium-99m (Tc-99m) is a widely used radioisotope for medical imaging.
Purpose of the Study:
- To evaluate the stability and sensitivity of Tc-99m-labeled sucralfate for detecting gastrointestinal ulcers.
- To assess the clinical utility of this novel radiotracer.
Main Methods:
- Development of a method for labeling sucralfate with Tc-99m.
- In vivo studies in rabbits with experimentally induced gastric ulcers.
- Clinical evaluation in human subjects with suspected gastrointestinal ulcer disease.
Main Results:
- Tc-99m-labeled sucralfate demonstrated in vivo stability and good sensitivity in preliminary studies.
- Eight experimentally produced gastric ulcers in rabbits were successfully visualized.
- In seven human studies, four true-positive and three true-negative results were obtained.
Conclusions:
- Tc-99m-labeled sucralfate is a stable and sensitive agent for visualizing gastrointestinal ulcers.
- This radiotracer may offer significant clinical advantages for evaluating gastrointestinal ulcer disease and mucosal integrity loss.